Today, on the 6th annual National Women and Girls HIV/AIDS Awareness Day, NIAID encourages healthy and HIV-positive volunteers to help fight HIV/AIDS by participating in clinical trials. Women and girls are estimated to account for half of all people living with HIV. In 2009, HIV/AIDS was the leading cause of disease and death among women between the ages of 15 and 44. NIAID is committed to research that helps reduce the incidence and improve the treatment of HIV/AIDS in women and girls in the United States and around the world.
Learn more about NIAID’s role in women’s health research, including clinical trials, and share NIAID’s Women and Girls HIV/AIDS Awareness Day eCard: NIAID eCard.
Women's HealthWomen face unique health problems related to many of NIAID’s mission areas—specifically, HIV/AIDS, sexually transmitted infections (STIs), and autoimmune disorders. Many infectious and autoimmune diseases affect female populations disproportionately. For example, genital herpes from herpes simplex virus 2 is nearly twice as common among women as among men. Likewise, women account for more cases of chlamydia, lupus, and scleroderma than do men.
Even diseases that strike men and women in nearly equal numbers may have unique consequences or complications for women. For instance, women with HIV are at higher risk of severe cases of gynecological problems, such as chlamydia or bacterial vaginosis, than are non-infected women. Women also risk passing some of these diseases to children during pregnancy or breastfeeding.
full-text:
Women's Health, NIAID, NIH
0 comentarios:
Publicar un comentario en la entrada